Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 15, 2023 - Issue
Submit an article Journal homepage
626
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?

Elisabeth M Jongbloed1 Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the NetherlandsCorrespondence[email protected]
,
Hedwig M Blommestein2 Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands
,
Hannah M van Schoubroeck2 Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands
,
John WM Martens1 Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands
,
Saskia M Wilting1 Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the NetherlandsORCID Iconhttps://orcid.org/0000-0002-2838-841X
ORCID Icon,
Carin A Uyl-de Groot2 Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands
&
Agnes Jager1 Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands
 show all
Pages 147-161 | Received 19 Sep 2022, Accepted 19 Jan 2023, Published online: 16 Feb 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.